Skip to content

Search Results

No Matching Results

    Recently Viewed


      HomeLatest newsCaring & giving9 ways Johnson & Johnson is sharing its vision for good with the world
      People given cataract surgeries by Himalayan Cataract Project, an organization devoted to eliminating preventable and curable blindness

      9 ways Johnson & Johnson is sharing its vision for good with the world

      For World Sight Day, we share stats about how the company is helping expand eye care across the globe through advocacy, education and sustainable innovation.

      Share Article
      share to

      More than 1 billion people around the world are living with vision impairment because they don’t have access to eye care or treatment.

      It’s a fact that Johnson & Johnson Vision is determined to help change, and one that’s even more apparent now that the COVID-19 pandemic has shined a spotlight on the health disparities that exist across the globe: According to the World Health Organization, the burden of eye conditions and vision impairment is far greater in people such as those with low incomes, ethnic minorities and indigenous populations.

      Through partnerships and scientific innovation, Johnson & Johnson Vision is aiming to tackle these health hurdles while also focusing on ensuring a healthier planet for generations to come, by reducing its carbon footprint, limiting landfill contribution and protecting natural resources. Recently, for example, Johnson & Johnson Vision signed a 10-year power purchase agreement with a solar farm to cover 100% of the electricity consumption of its headquarters in Jacksonville, Florida.

      Here, key highlights from the Johnson & Johnson Vision 2020 impact report, Vision for Good, which launched this month and details the strides the company has already made toward these goals.


      Read the 2020 Johnson & Johnson Vision Impact Report

      Access the full report to learn more about how the company is working to improve vision around the world.

      More from Johnson & Johnson

      Meet a nurse who leads clinical trials to find innovative cancer therapies

      Melissa Martinez is a clinical scientist within Johnson & Johnson’s Interventional Oncology R&D group. Not only is she helping to develop lifesaving treatments, she’s redefining what it means to pursue a career in nursing.

      What’s the difference between IBS and IBD?

      These GI conditions sound similar, and they also share some symptoms. But IBS and IBD are distinct disorders—especially when it comes to treatment and the risk of complications.

      How robots are helping personalize knee replacement surgery

      For Arthritis Awareness Month, learn the latest about this common procedure and how Johnson & Johnson MedTech is innovating to improve patient outcomes.
      You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.